Recent developments show limited prospects for congressional approval of any comprehensive U.S.-Iran nuclear or sanctions agreement in 2026. A June memorandum of understanding signed by the Trump administration initiated a 60-day negotiation window on nuclear issues and sanctions relief under the framework of the Iran Nuclear Agreement Review Act (INARA), which mandates congressional review for deals involving Iran's nuclear program. However, bipartisan skepticism persists, with Republican senators emphasizing requirements for full enrichment dismantlement, missile restrictions, and terrorism-related conditions before any sanctions relief. Multiple war powers resolutions passed both chambers this summer to curb U.S. military involvement, reflecting congressional pushback amid resumed hostilities. Ongoing technical talks have produced no finalized text submitted for legislative action, leaving the path to passage blocked by partisan divides and procedural hurdles.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCongress approves Iran deal in 2026?
$12,413 Vol.
$12,413 Vol.
$12,413 Vol.
$12,413 Vol.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
Market Opened: Jun 16, 2026, 2:24 PM ET
Resolver
0x65070BE91...A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Recent developments show limited prospects for congressional approval of any comprehensive U.S.-Iran nuclear or sanctions agreement in 2026. A June memorandum of understanding signed by the Trump administration initiated a 60-day negotiation window on nuclear issues and sanctions relief under the framework of the Iran Nuclear Agreement Review Act (INARA), which mandates congressional review for deals involving Iran's nuclear program. However, bipartisan skepticism persists, with Republican senators emphasizing requirements for full enrichment dismantlement, missile restrictions, and terrorism-related conditions before any sanctions relief. Multiple war powers resolutions passed both chambers this summer to curb U.S. military involvement, reflecting congressional pushback amid resumed hostilities. Ongoing technical talks have produced no finalized text submitted for legislative action, leaving the path to passage blocked by partisan divides and procedural hurdles.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions